The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The role of IKK in constitutive activation of NF-κB transcription factor in prostate carcinoma cells
Abstract
Rel/NF-κB transcription factors are implicated in the control of cell proliferation, apoptosis and transformation. The key to NF-κB regulation is the inhibitory IκB proteins. During response to diverse stimuli, IκBs are rapidly phosphorylated by IκB kinases (IKKs), ubiquitinated and undergo degradation. We have investigated the expression and function of NF-κB, IκB inhibitors and IKKs in normal prostate epithelial cells and prostate carcinoma (PC) cell lines LNCaP, MDA PCa 2b, DU145, PC3, and JCA1. We found that NF-κB was constitutively activated in human androgen-independent PC cell lines DU145, PC3, JCA1 as well as androgen-independent CL2 cells derived from LNCaP. In spite of a strong difference in constitutive κB binding, Western blot analysis did not reveal any significant variance in the expression of p50, p65, IκBs, IKKα, and IKKβ between primary prostate cells, androgen-dependent and androgen-independent PC cells. However, we found that in androgen-independent PC cells IκBα was heavily phosphorylated and displayed a faster turnover. Using an in vitro kinase assay we demonstrated constitutive activation of IKK in androgen-independent PC cell lines. Blockage of NF-κB activity in PC cells by dominant-negative IκBα resulted in increased constitutive and TNF-α-induced apoptosis. Our data suggest that increased IKK activation leads to the constitutive activation of NF-κB ‘survival signaling’ pathway in androgen-independent PC cells. This may be important for the support of their androgen-independent status and growth advantage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
A simplified system for generating recombinant adenoviruses
He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,206
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation
Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M., Mann, M., Manning, A., et al. (1997) · Science · doi:10.1126/science.278.5339.860 · Cited by 2,040
Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., & Karin, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80406-7 · Cited by 1,812
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Control of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,204
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., & Israël, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81466-x · Cited by 1,076
Traenckner, E. B., Pahl, H. L., Henkel, T., Schmidt, K. N., Wilk, S., & Baeuerle, P. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07287.x · Cited by 1,013
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C., & Strauss, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2690 · Cited by 788
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Biswas, D. K., Cruz, A. P., Gansberger, E., & Pardee, A. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8542 · Cited by 351
Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα
Cabannes, E., Khan, G., Aillet, F., Jarrett, R. F., & Hay, R. T. (1999) · Oncogene · doi:10.1038/sj.onc.1202893 · Cited by 334
IκB proteins: structure, function and regulation
Whiteside, S. T., & Israël, A. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0058 · Cited by 324
Le Bail, O., Schmidt-Ullrich, R., & Israël, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06197.x · Cited by 323
Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen
Palayoor, S. T., Youmell, M. Y., Calderwood, S. K., Coleman, C. N., & Price, B. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203160 · Cited by 317
Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
Krappmann, D., Emmerich, F., Kordes, U., Scharschmidt, E., Dörken, B., & Scheidereit, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202351 · Cited by 271
Duffey, D. C., Chen, Z., Dong, G., Ondrey, F. G., Wolf, J. S., Brown, K., Siebenlist, U. K., & Waes, C. V. (1999) · PubMed · Cited by 263
Emmerich, F., Meiser, M., Hummel, M., Demel, G., Foss, H.-D., Jundt, F., Mathas, S., Krappmann, D., Scheidereit, C., Stein, H., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3129 · Cited by 261
Catalysis by a Multiprotein IκB Kinase Complex
Maniatis, T. (1997) · Science · doi:10.1126/science.278.5339.818 · Cited by 254
Whiteside, S. T., Ernst, M. K., LeBail, O., Laurent-Winter, C., Rice, N., & Alain, I. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5339 · Cited by 222
Mutual Transcriptional Interference between RelA and Androgen Receptor
Palvimo, J. J., Reinikainen, P., Ikonen, T., Kallio, P. J., Moilanen, A., & Jänne, O. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24151 · Cited by 214
NF-kappa B p105 is a target of Ikappa B kinases and controls signal induction of Bcl-3-p50 complexes
Heissmeyer, V. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4766 · Cited by 197
Krappmann, D., Wulczyn, F. G., & Scheidereit, C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01061.x · Cited by 190
Zhang, Y., Broser, M., & Rom, W. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2225 · Cited by 189
Visconti, R., Cerutti, J., Battista, S., Fedele, M., Trapasso, F., Zeki, K., Miano, M. P., de Nigris, F., Casalino, L., Curcio, F., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201373 · Cited by 168
Supakar, P. C., Jung, M. H., Song, C. S., Chatterjee, B., & Roy, A. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.837 · Cited by 146
Phenotypic and genotypic characterization of commonly used human prostatic cell lines
Mitchell, S., Abel, P. D., Ware, M., Stamp, G., & Lalani, E. (2000) · British Journal of Urology · doi:10.1046/j.1464-410x.2000.00606.x · Cited by 137
Sun, L., & Carpenter, G. F. (1998) · Oncogene · doi:10.1038/sj.onc.1201731 · Cited by 129
Dejardin, E., Bonizzi, G., Bellahcène, A., Castronovo, V., Merville, M.-P., & Bours, V. (1995) · PubMed · Cited by 124
Budunova, I. V., Pérez, P., Vaden, V. R., Spiegelman, V. S., Slaga, T. J., & Jorcano, J. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203104 · Cited by 119
Self-citationNovel IκBα Proteolytic Pathway in WEHI231 Immature B Cells
Miyamoto, S., Seufzer, B. J., & Shumway, S. D. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.19 · Cited by 115
O’Mahony, A., Lin, X., Geleziunas, R., & Greene, W. C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1170-1178.2000 · Cited by 112
Lyakh, L. A., Koski, G. K., Telford, W. G., Gress, R. E., Cohen, P. A., & Rice, N. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3647 · Cited by 112
Self-citationGentry, J. J., Casaccia‐Bonnefil, P., & Carter, B. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7558 · Cited by 110
Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells
Dejardin, E., Deregowski, V., Chapelier, M., Jacobs, N., GIELEN, J. E., Merville, M., & Bours, V. (1999) · Oncogene · doi:10.1038/sj.onc.1202599 · Cited by 110
Valentine, J. E., Kalkhoven, E., White, R., Hoare, S., & Parker, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002497200 · Cited by 108
Sumitomo, M., Tachibana, M., Nakashima, J., Murai, M., Miyajima, A., Kimura, F., Hayakawa, M., & Nakamura, H. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61993-1 · Cited by 108
Devalaraja, M. N., Wang, D. Z., Ballard, D. W., & Richmond, A. J. (1999) · PubMed · Cited by 87
Byrd, V. M., Ballard, D. W., Miller, G. G., & Thomas, J. W. (1999) · PubMed · Cited by 53
Establishment of new human prostatic cancer cell line (JCA-I)
Muraki, J., Addonizio, J. C., Choudhury, M. S., Fischer, J., Eshghi, M., Davidian, M. M., Shapiro, L. R., Wilmot, P. L., Nagamatsu, G. R., & Chiao, J. W. (1990) · Urology · doi:10.1016/0090-4295(90)80319-i · Cited by 49
Byrd, V. M., Ballard, D. W., Miller, G. G., & Thomas, J. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5853 · Cited by 48
Bours, V., Azarenko, V., Dejardin, E., & Siebenlist, U. K. (1994) · PubMed · Cited by 39
Cited by
Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation
Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.009 · Cited by 1,496
NF‐κB and the link between inflammation and cancer
DiDonato, J. A., Mercurio, F., & Karin, M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01099.x · Cited by 1,482
NF- B as a Critical Link Between Inflammation and Cancer
Karin, M. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000141 · Cited by 816
Nuclear Factor-κB Activation: From Bench to Bedside
Sethi, G., Sung, B., & Aggarwal, B. B. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-196 · Cited by 417
Xu, C., Shen, G., Chen, C., Gélinas, C., & Kong, A.-N. T. (2005) · Oncogene · doi:10.1038/sj.onc.1208656 · Cited by 301
Metadata
- Authors
- Gasparian, A. V., Yao, Y. J., Kowalczyk, D., Lyakh, L. A., Karseladze, A., Slaga, T. J., & Budunova, I. V.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2002-01-01
- Volume
- 115
- Issue
- 1
- Pages
- 141-151
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W1807380980
- Cited by
- 275
- References
- 48
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.